首页 > 最新文献

Frontiers in Cellular and Infection Microbiology最新文献

英文 中文
Hepatitis B virus RNA and hepatitis B surface antigen kinetics predict treatment outcomes in children with chronic hepatitis B. 乙型肝炎病毒RNA和乙型肝炎表面抗原动力学预测慢性乙型肝炎儿童的治疗结果。
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-03 eCollection Date: 2026-01-01 DOI: 10.3389/fcimb.2026.1746541
Xiaorong Peng, Yunan Chang, Jiaying Wu, Jing Zhu, Peng Hu, Hong Ren, Hongmei Xu, Ruiqiu Zhao, Tao Qin

Background: Serum hepatitis B virus (HBV) pregenomic RNA (pgRNA) predicts antiviral response in adults with chronic hepatitis B (CHB); however, its prognostic performance against conventional biomarkers in children remains underexplored. This study aimed to characterize the kinetics of pgRNA and hepatitis B surface antigen (HBsAg) and evaluate their predictive value for treatment outcomes in children with CHB.

Methods: Sixty-five hepatitis B e antigen (HBeAg)-positive children with CHB who received ≥ 96 weeks of nucleos(t)ide analogue (NA) therapy were included. Serum viral biomarkers were measured at baseline, weeks 12, 48, and 96. Treatment outcomes were HBeAg seroconversion and HBsAg loss (Defined as HBsAg <100 IU/mL or seroclearance).

Results: Patients initiating treatment before age 7 years had a significantly higher cumulative incidence of HBeAg seroconversion (73.5% vs. 48.4%) and HBsAg loss (50.0% vs. 9.7%) compared to older children (p < 0.05). Week 12 HBV pgRNA decline was an independent predictor of HBeAg seroconversion (area under the curve [AUC] = 0.793, 95% confidence interval [CI]: 0.686-0.900), outperforming HBV DNA and HBsAg kinetics. For predicting HBsAg loss, the week 12 HBsAg decline was an independent predictor (AUC = 0.762, 95% CI: 0.632-0.893), and its integration with patient age further improved predictive accuracy (AUC = 0.879, 95% CI: 0.796-0.962).

Conclusions: Early pgRNA kinetics more accurately predict HBeAg seroconversion, whereas HBsAg dynamics forecast HBsAg loss more effectively, particularly when combined with patient age. This complementary monitoring strategy provides a clinically applicable tool for optimizing personalized management in children with CHB.

背景:血清乙型肝炎病毒(HBV)基因组前RNA (pgRNA)预测成人慢性乙型肝炎(CHB)患者的抗病毒反应;然而,其对儿童常规生物标志物的预后表现仍未得到充分探索。本研究旨在表征pgRNA和乙型肝炎表面抗原(HBsAg)的动力学特征,并评估它们对慢性乙型肝炎儿童治疗结果的预测价值。方法:65例乙型肝炎e抗原(HBeAg)阳性的CHB患儿接受≥96周的核苷(t)类似物(NA)治疗。在基线、第12周、第48周和第96周测量血清病毒生物标志物。治疗结果是HBeAg血清转化和HBsAg损失(定义为HBsAg结果:7岁前开始治疗的患者与年龄较大的儿童相比,HBeAg血清转化(73.5%对48.4%)和HBsAg损失(50.0%对9.7%)的累积发生率显著更高(p结论:早期pgRNA动力学更准确地预测HBeAg血清转化,而HBsAg动力学更有效地预测HBsAg损失,特别是与患者年龄相结合时。这种补充监测策略为优化慢性乙型肝炎儿童的个性化管理提供了一种临床适用的工具。
{"title":"Hepatitis B virus RNA and hepatitis B surface antigen kinetics predict treatment outcomes in children with chronic hepatitis B.","authors":"Xiaorong Peng, Yunan Chang, Jiaying Wu, Jing Zhu, Peng Hu, Hong Ren, Hongmei Xu, Ruiqiu Zhao, Tao Qin","doi":"10.3389/fcimb.2026.1746541","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1746541","url":null,"abstract":"<p><strong>Background: </strong>Serum hepatitis B virus (HBV) pregenomic RNA (pgRNA) predicts antiviral response in adults with chronic hepatitis B (CHB); however, its prognostic performance against conventional biomarkers in children remains underexplored. This study aimed to characterize the kinetics of pgRNA and hepatitis B surface antigen (HBsAg) and evaluate their predictive value for treatment outcomes in children with CHB.</p><p><strong>Methods: </strong>Sixty-five hepatitis B e antigen (HBeAg)-positive children with CHB who received ≥ 96 weeks of nucleos(t)ide analogue (NA) therapy were included. Serum viral biomarkers were measured at baseline, weeks 12, 48, and 96. Treatment outcomes were HBeAg seroconversion and HBsAg loss (Defined as HBsAg <100 IU/mL or seroclearance).</p><p><strong>Results: </strong>Patients initiating treatment before age 7 years had a significantly higher cumulative incidence of HBeAg seroconversion (73.5% vs. 48.4%) and HBsAg loss (50.0% vs. 9.7%) compared to older children (<i>p</i> < 0.05). Week 12 HBV pgRNA decline was an independent predictor of HBeAg seroconversion (area under the curve [AUC] = 0.793, 95% confidence interval [CI]: 0.686-0.900), outperforming HBV DNA and HBsAg kinetics. For predicting HBsAg loss, the week 12 HBsAg decline was an independent predictor (AUC = 0.762, 95% CI: 0.632-0.893), and its integration with patient age further improved predictive accuracy (AUC = 0.879, 95% CI: 0.796-0.962).</p><p><strong>Conclusions: </strong>Early pgRNA kinetics more accurately predict HBeAg seroconversion, whereas HBsAg dynamics forecast HBsAg loss more effectively, particularly when combined with patient age. This complementary monitoring strategy provides a clinically applicable tool for optimizing personalized management in children with CHB.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1746541"},"PeriodicalIF":4.8,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146217936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid-reproductive axis interplay: immunological mechanisms and implications for female reproductive health. 甲状腺-生殖轴相互作用:免疫机制及其对女性生殖健康的影响。
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2025-01-01 DOI: 10.3389/fcimb.2025.1653380
Sisi Chen, Shahid Ullah Khan, Safir Ullah Khan, Mohammed Alissa, Essam H Ibrahim, Saleem Ahmad, Ramadan Taha, Kun Zhou

Thyroid dysfunction is a common endocrine disease among women of childbearing age, which seriously affects reproductive health. From an immunological perspective, this in-depth analysis clarifies the complex relationship between thyroid function and female reproduction. We studied the hypothalamic-pituitary-gonadal axis regulation by thyroid hormones through direct and indirect mechanisms, including metabolic mediators such as prolactin and leptin. Recent studies have shown that inflammatory cytokines (IL-1α, IL-1β, IL-6, IFN-γ, and TNF-α) severely disrupt the production pathways of thyroid hormones, establishing an essential link between immune activation and reproductive problems. Since the placenta serves as an active immune interface affected by thyroid activity, there are significant physiological obstacles (including increased iodine clearance and elevated deiodinase activity), immunological challenges (such as altered cytokine profiles), and pathological barriers to optimal thyroid adaptation during pregnancy. This literature review indicates that thyroid problems substantially affect reproductive outcomes by altering the immune response at the maternal-fetal interface, influencing placental development, trophoblast invasion, and vascular remodeling. This review addresses a notable research deficiency through a modern perspective on thyroid dysfunction and reproductive issues, especially inflammatory cytokines related to preeclampsia. We believe that thyroid dysfunction can alter the expression of specific angiogenic factors (including sFlt-1, PlGF, and VEGF) and modify the immune cell profile at the maternal-fetal interface (particularly NK cells, macrophages, and T regulatory cells), creating a new framework for understanding and addressing thyroid-related reproductive diseases through targeted immunomodulatory strategies.

甲状腺功能障碍是育龄妇女常见的内分泌疾病,严重影响生殖健康。从免疫学角度深入分析,阐明了甲状腺功能与女性生殖之间的复杂关系。我们通过直接和间接机制研究了甲状腺激素对下丘脑-垂体-性腺轴的调节,包括催乳素和瘦素等代谢介质。最近的研究表明,炎症因子(IL-1α、IL-1β、IL-6、IFN-γ和TNF-α)严重破坏甲状腺激素的产生途径,在免疫激活和生殖问题之间建立了重要的联系。由于胎盘是受甲状腺活动影响的主动免疫界面,因此在妊娠期间存在显著的生理障碍(包括碘清除率增加和去碘酶活性升高)、免疫挑战(如细胞因子谱改变)和最佳甲状腺适应的病理障碍。这篇文献综述表明,甲状腺问题通过改变母胎界面的免疫反应、影响胎盘发育、滋养细胞侵袭和血管重塑,从而实质性地影响生殖结果。这篇综述通过对甲状腺功能障碍和生殖问题的现代观点,特别是与子痫前期相关的炎症细胞因子,解决了一个值得注意的研究缺陷。我们认为,甲状腺功能障碍可以改变特定血管生成因子(包括sFlt-1、PlGF和VEGF)的表达,并改变母胎界面的免疫细胞谱(特别是NK细胞、巨噬细胞和T调节细胞),从而通过靶向免疫调节策略为理解和解决甲状腺相关生殖疾病创造了新的框架。
{"title":"Thyroid-reproductive axis interplay: immunological mechanisms and implications for female reproductive health.","authors":"Sisi Chen, Shahid Ullah Khan, Safir Ullah Khan, Mohammed Alissa, Essam H Ibrahim, Saleem Ahmad, Ramadan Taha, Kun Zhou","doi":"10.3389/fcimb.2025.1653380","DOIUrl":"https://doi.org/10.3389/fcimb.2025.1653380","url":null,"abstract":"<p><p>Thyroid dysfunction is a common endocrine disease among women of childbearing age, which seriously affects reproductive health. From an immunological perspective, this in-depth analysis clarifies the complex relationship between thyroid function and female reproduction. We studied the hypothalamic-pituitary-gonadal axis regulation by thyroid hormones through direct and indirect mechanisms, including metabolic mediators such as prolactin and leptin. Recent studies have shown that inflammatory cytokines (IL-1α, IL-1β, IL-6, IFN-γ, and TNF-α) severely disrupt the production pathways of thyroid hormones, establishing an essential link between immune activation and reproductive problems. Since the placenta serves as an active immune interface affected by thyroid activity, there are significant physiological obstacles (including increased iodine clearance and elevated deiodinase activity), immunological challenges (such as altered cytokine profiles), and pathological barriers to optimal thyroid adaptation during pregnancy. This literature review indicates that thyroid problems substantially affect reproductive outcomes by altering the immune response at the maternal-fetal interface, influencing placental development, trophoblast invasion, and vascular remodeling. This review addresses a notable research deficiency through a modern perspective on thyroid dysfunction and reproductive issues, especially inflammatory cytokines related to preeclampsia. We believe that thyroid dysfunction can alter the expression of specific angiogenic factors (including sFlt-1, PlGF, and VEGF) and modify the immune cell profile at the maternal-fetal interface (particularly NK cells, macrophages, and T regulatory cells), creating a new framework for understanding and addressing thyroid-related reproductive diseases through targeted immunomodulatory strategies.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"15 ","pages":"1653380"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and laboratory characteristics of patients infected with Shewanella species at a tertiary hospital in Hefei City, China: a retrospective analysis. 合肥市某三级医院希瓦氏菌感染患者的临床和实验室特征:回顾性分析
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.3389/fcimb.2026.1700922
Xiangyun Li, Xiaoqin Deng, Jun Xu, Boke Zhang, Xinyu Yan, Yuanhong Xu

Introduction: Shewanella species (Shewanella spp.) were emerging and rare pathogens. Very few studies had focused on Shewanella spp. infection due to its low incidence. A retrospective analysis summarizing clinical and laboratory characteristics of Shewanella spp. infection at a tertiary hospital in Hefei City was conducted to learn more about the rare bacterium.

Methods: A total of 36 patients with Shewanella spp. infection from October 2019 to February 2025 were included. The data of all patients were collected by reviewing electronic records.

Results: Among 36 isolated strains, 77.8% were Shewanella algae and 22.2% were Shewanella putrefaciens. Abdominal pain was the most common clinical symptom. Intrahepatic stone and cholangitis was the main diagnosed disease. According to the type of main diagnosed disease, they were divided into two groups: hepatobiliary disease group and non-hepatobiliary disease group. The laboratory results were analyzed, and it was revealed that the laboratory characteristics of anemia, neutrophilia, leukocytosis, and so on were common. Serum coagulation tests results showed that it was significantly higher than the normal value, and all other serum biochemical and coagulation tests results were mostly normal. For microorganism culture, co-infection microorganisms were obtained. Shewanella spp. were usually susceptible to aminoglycoside, quinolone, cephalosporin, carbapenems, and compound antibiotics. All patients were treated with antibiotics, and there were one or more types of antibiotics to use, all of whom had effective treatment outcomes.

Discussion: Shewanella spp. infections were very limited. The study might improve the attention and awareness of the rare bacterial infection.

谢氏菌属(Shewanella)是一种新兴的、罕见的致病菌。由于希瓦氏菌感染的发病率较低,因此很少有研究关注其感染。对合肥市某三级医院希瓦氏菌感染的临床和实验室特点进行回顾性分析,以进一步了解这种罕见的细菌。方法:选取2019年10月至2025年2月收治的36例希瓦氏菌感染患者。所有患者的资料均通过查阅电子病历的方式收集。结果:36株分离菌株中,希瓦氏菌藻类占77.8%,腐坏希瓦氏菌占22.2%。腹痛是最常见的临床症状。主要诊断为肝内结石和胆管炎。根据主要诊断疾病的类型分为两组:肝胆疾病组和非肝胆疾病组。对实验室结果进行分析,发现贫血、嗜中性粒细胞增多、白细胞增多等实验室特征较为常见。血清凝血试验结果明显高于正常值,其他血清生化及凝血试验结果基本正常。微生物培养获得共感染微生物。希瓦氏菌对氨基糖苷类、喹诺酮类、头孢菌素类、碳青霉烯类及复合抗生素敏感。所有患者均接受抗生素治疗,使用一种或多种抗生素,均有有效的治疗效果。讨论:希瓦氏菌感染非常有限。该研究可能会提高人们对罕见细菌感染的关注和认识。
{"title":"Clinical and laboratory characteristics of patients infected with <i>Shewanella</i> species at a tertiary hospital in Hefei City, China: a retrospective analysis.","authors":"Xiangyun Li, Xiaoqin Deng, Jun Xu, Boke Zhang, Xinyu Yan, Yuanhong Xu","doi":"10.3389/fcimb.2026.1700922","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1700922","url":null,"abstract":"<p><strong>Introduction: </strong><i>Shewanella</i> species (<i>Shewanella</i> spp.) were emerging and rare pathogens. Very few studies had focused on <i>Shewanella</i> spp. infection due to its low incidence. A retrospective analysis summarizing clinical and laboratory characteristics of <i>Shewanella</i> spp. infection at a tertiary hospital in Hefei City was conducted to learn more about the rare bacterium.</p><p><strong>Methods: </strong>A total of 36 patients with <i>Shewanella</i> spp. infection from October 2019 to February 2025 were included. The data of all patients were collected by reviewing electronic records.</p><p><strong>Results: </strong>Among 36 isolated strains, 77.8% were <i>Shewanella algae</i> and 22.2% were <i>Shewanella putrefaciens</i>. Abdominal pain was the most common clinical symptom. Intrahepatic stone and cholangitis was the main diagnosed disease. According to the type of main diagnosed disease, they were divided into two groups: hepatobiliary disease group and non-hepatobiliary disease group. The laboratory results were analyzed, and it was revealed that the laboratory characteristics of anemia, neutrophilia, leukocytosis, and so on were common. Serum coagulation tests results showed that it was significantly higher than the normal value, and all other serum biochemical and coagulation tests results were mostly normal. For microorganism culture, co-infection microorganisms were obtained. <i>Shewanella</i> spp. were usually susceptible to aminoglycoside, quinolone, cephalosporin, carbapenems, and compound antibiotics. All patients were treated with antibiotics, and there were one or more types of antibiotics to use, all of whom had effective treatment outcomes.</p><p><strong>Discussion: </strong><i>Shewanella</i> spp. infections were very limited. The study might improve the attention and awareness of the rare bacterial infection.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1700922"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system. 白喉-破伤风-无细胞百日咳疫苗在7岁以下儿童中的安全性:美国疫苗不良事件报告系统的上市后分析
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.3389/fcimb.2026.1733777
Meishen Liu, Xueying Zhou, Linshu Guan, Hening Sun, Zhaohui Bai, Yalin Xi, Xinkuo Zheng

Objectives: Although Diphtheria-Tetanus-acellular Pertussis (DTaP) vaccines have been used in the U.S. for decades and have extensive safety records, a comprehensive post-marketing assessment for all available types is still needed. This study leveraged the Vaccine Adverse Event Reporting System (VAERS) database to evaluate adverse events following immunization (AEFI) and analyze potential associations with vaccine administration.

Methods: We extracted all reports of adverse events (AEs) following DTaP vaccination from the VAERS database for the period 1990 to May 2025. Our analysis included descriptive statistics to summarize patient demographics and clinical features, and disproportionality methods to identify potential safety signals.

Results: During the study period, the VAERS database documented 57,341 children under 7 years who received DTaP vaccines, corresponding to 57,368 administered doses and 193,955 adverse event (AE) reports. AE reporting was more frequent in males (52.46%) than females (45.07%), with more than half of the cases (50.44%) involving children under 2 years old. The most common clinical outcomes were recovery (62.53%) and hospitalization (10.29%). Most AEs (89.61%) occurred within 0-30 days after vaccination, with a median onset time of 1.0 days. Infanrix (37.95%) and Daptacel (25.04%) were the most frequently reported vaccine types. Disproportionality analysis detected 158 positive AE signals across 24 system organ classes (SOCs). Among all SAEs, pyrexia (ROR = 1.01) was the most frequently reported, followed by convulsion (ROR = 1.82) and vomiting (ROR = 1.05). The most common signals for non-SAEs included injection site erythema (ROR = 3.79), injection site swelling (ROR = 3.00), and erythema (ROR = 3.03).

Conclusions: This post-marketing surveillance indicates that most reported AEs were non-serious and occurred within 30 days following vaccination. These findings support the known safety profile of DTaP vaccines and highlight identifiable timing patterns of AEs, which may help inform monitoring strategies and benefit-risk assessments after immunization.

虽然白喉-破伤风-无细胞百日咳(DTaP)疫苗在美国已经使用了几十年,并且有广泛的安全记录,但仍然需要对所有可用类型进行全面的上市后评估。本研究利用疫苗不良事件报告系统(VAERS)数据库来评估免疫后不良事件(AEFI),并分析与疫苗接种的潜在关联。方法:我们从VAERS数据库中提取1990年至2025年5月期间接种DTaP疫苗后的所有不良事件(ae)报告。我们的分析包括描述性统计来总结患者人口统计学和临床特征,以及歧化方法来识别潜在的安全信号。结果:在研究期间,VAERS数据库记录了57,341名7岁以下儿童接种DTaP疫苗,对应于57,368次给药剂量和193,955例不良事件(AE)报告。AE报告中男性(52.46%)高于女性(45.07%),超过一半(50.44%)的病例涉及2岁以下儿童。最常见的临床结局是康复(62.53%)和住院(10.29%)。大多数ae(89.61%)发生在疫苗接种后0 ~ 30天,中位发病时间为1.0天。Infanrix(37.95%)和Daptacel(25.04%)是报告最多的疫苗类型。歧化分析在24个系统器官类别(soc)中检测到158个阳性声发射信号。在所有SAEs中,最常见的是发热(ROR = 1.01),其次是惊厥(ROR = 1.82)和呕吐(ROR = 1.05)。非saes最常见的信号包括注射部位红斑(ROR = 3.79)、注射部位肿胀(ROR = 3.00)和红斑(ROR = 3.03)。结论:这项上市后监测表明,大多数报告的不良反应不严重,发生在接种疫苗后30天内。这些发现支持了DTaP疫苗的已知安全性,并强调了ae的可识别时间模式,这可能有助于为免疫接种后的监测策略和利益风险评估提供信息。
{"title":"Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system.","authors":"Meishen Liu, Xueying Zhou, Linshu Guan, Hening Sun, Zhaohui Bai, Yalin Xi, Xinkuo Zheng","doi":"10.3389/fcimb.2026.1733777","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1733777","url":null,"abstract":"<p><strong>Objectives: </strong>Although Diphtheria-Tetanus-acellular Pertussis (DTaP) vaccines have been used in the U.S. for decades and have extensive safety records, a comprehensive post-marketing assessment for all available types is still needed. This study leveraged the Vaccine Adverse Event Reporting System (VAERS) database to evaluate adverse events following immunization (AEFI) and analyze potential associations with vaccine administration.</p><p><strong>Methods: </strong>We extracted all reports of adverse events (AEs) following DTaP vaccination from the VAERS database for the period 1990 to May 2025. Our analysis included descriptive statistics to summarize patient demographics and clinical features, and disproportionality methods to identify potential safety signals.</p><p><strong>Results: </strong>During the study period, the VAERS database documented 57,341 children under 7 years who received DTaP vaccines, corresponding to 57,368 administered doses and 193,955 adverse event (AE) reports. AE reporting was more frequent in males (52.46%) than females (45.07%), with more than half of the cases (50.44%) involving children under 2 years old. The most common clinical outcomes were recovery (62.53%) and hospitalization (10.29%). Most AEs (89.61%) occurred within 0-30 days after vaccination, with a median onset time of 1.0 days. Infanrix (37.95%) and Daptacel (25.04%) were the most frequently reported vaccine types. Disproportionality analysis detected 158 positive AE signals across 24 system organ classes (SOCs). Among all SAEs, pyrexia (ROR = 1.01) was the most frequently reported, followed by convulsion (ROR = 1.82) and vomiting (ROR = 1.05). The most common signals for non-SAEs included injection site erythema (ROR = 3.79), injection site swelling (ROR = 3.00), and erythema (ROR = 3.03).</p><p><strong>Conclusions: </strong>This post-marketing surveillance indicates that most reported AEs were non-serious and occurred within 30 days following vaccination. These findings support the known safety profile of DTaP vaccines and highlight identifiable timing patterns of AEs, which may help inform monitoring strategies and benefit-risk assessments after immunization.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1733777"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Garcinone C inhibits pseudorabies virus replication through EGF/PI3K/Akt axis. Garcinone C通过EGF/PI3K/Akt轴抑制伪狂犬病毒复制。
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2025-01-01 DOI: 10.3389/fcimb.2025.1722752
Changjie Lv, Shuang Wang, Zhongyuan Jin, Jiaxin Zhang, Yajie Peng, Jinmiao Chen

Introduction: Pseudorabies virus (PRV), a significant pathogen of swine, causes substantial economic losses, and even poses an emergent public health concern due to its zoonotic potential. The continuous evolution of PRV has undermined the effectiveness of current vaccines and antiviral drugs. Consequently, there is an urgent need to develop novel strategies to curb its spread.

Methods: The inhibitory effect of garcinone C on PRV replication was assessed in vivo and in vitro. To determine the stage of antiviral action, treatments were administered at different time points: pre-treatment, co-treatment, and post-infection. RNA sequencing was performed, and differentially expressed genes (DEGs) were identified.

Results: In the study, we found that garcinone C inhibited PRV replication in a concentration- and timedependent manner in vitro. The antiviral activity of garcinone C was specific to post-infection administration and did not extend to pre-treatment and cotreatment conditions. Transcriptomic analysis identified DEGs between garcinone C- and vehicle-treated cells after PRV infection. KEGG pathway enrichment analysis of the DEGs indicated that the antiviral effect of garcinone C was primarily associated with the PI3K-Akt signaling pathway, potentially through the downregulation of the host epidermal growth factor. Furthermore, garcinone C suppressed the production of key inflammatory cytokines such as IL-6, IL-8, and TNF-a during PRV infection. Oral administration of garcinone C conferred protection in PRVinfected mice, leading to attenuated weight loss, an improved survival rate, as well as reduced pathological changes and viral loads in tissues.

Discussion: Collectively, our findings identify garcinone C as a promising therapeutic candidate against PRV and elucidate its underlying molecular mechanism.

伪狂犬病毒(PRV)是一种重要的猪病原体,由于其人畜共患的潜力,造成了巨大的经济损失,甚至引起了紧急的公共卫生问题。PRV的不断演变削弱了现有疫苗和抗病毒药物的有效性。因此,迫切需要制定新的战略来遏制其传播。方法:观察garcinone C在体内和体外对PRV复制的抑制作用。为了确定抗病毒作用的阶段,在不同的时间点进行治疗:治疗前、联合治疗和感染后。进行RNA测序,鉴定差异表达基因(DEGs)。结果:在体外实验中,我们发现garcinone C对PRV的复制具有浓度和时间依赖性。garcinone C的抗病毒活性仅在感染后给予,而不扩展到治疗前和共治疗条件。转录组学分析发现,在PRV感染后,garcinone C和载体处理的细胞之间存在deg。KEGG通路富集分析表明,garcinone C的抗病毒作用主要与PI3K-Akt信号通路相关,可能通过下调宿主表皮生长因子来实现。此外,在PRV感染过程中,garcinone C抑制了关键炎症细胞因子如IL-6、IL-8和TNF-a的产生。口服garcinone C对prv感染小鼠具有保护作用,减轻了体重减轻,提高了存活率,减少了组织中的病理变化和病毒载量。讨论:总的来说,我们的研究结果确定了garcinone C作为抗PRV的有希望的治疗候选药物,并阐明了其潜在的分子机制。
{"title":"Garcinone C inhibits pseudorabies virus replication through EGF/PI3K/Akt axis.","authors":"Changjie Lv, Shuang Wang, Zhongyuan Jin, Jiaxin Zhang, Yajie Peng, Jinmiao Chen","doi":"10.3389/fcimb.2025.1722752","DOIUrl":"https://doi.org/10.3389/fcimb.2025.1722752","url":null,"abstract":"<p><strong>Introduction: </strong>Pseudorabies virus (PRV), a significant pathogen of swine, causes substantial economic losses, and even poses an emergent public health concern due to its zoonotic potential. The continuous evolution of PRV has undermined the effectiveness of current vaccines and antiviral drugs. Consequently, there is an urgent need to develop novel strategies to curb its spread.</p><p><strong>Methods: </strong>The inhibitory effect of garcinone C on PRV replication was assessed <i>in vivo</i> and <i>in vitro</i>. To determine the stage of antiviral action, treatments were administered at different time points: pre-treatment, co-treatment, and post-infection. RNA sequencing was performed, and differentially expressed genes (DEGs) were identified.</p><p><strong>Results: </strong>In the study, we found that garcinone C inhibited PRV replication in a concentration- and timedependent manner in vitro. The antiviral activity of garcinone C was specific to post-infection administration and did not extend to pre-treatment and cotreatment conditions. Transcriptomic analysis identified DEGs between garcinone C- and vehicle-treated cells after PRV infection. KEGG pathway enrichment analysis of the DEGs indicated that the antiviral effect of garcinone C was primarily associated with the PI3K-Akt signaling pathway, potentially through the downregulation of the host epidermal growth factor. Furthermore, garcinone C suppressed the production of key inflammatory cytokines such as IL-6, IL-8, and TNF-a during PRV infection. Oral administration of garcinone C conferred protection in PRVinfected mice, leading to attenuated weight loss, an improved survival rate, as well as reduced pathological changes and viral loads in tissues.</p><p><strong>Discussion: </strong>Collectively, our findings identify garcinone C as a promising therapeutic candidate against PRV and elucidate its underlying molecular mechanism.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"15 ","pages":"1722752"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sensitive, specific, and rapid on-site detection of calf diarrhea pathogens using the RPA-CRISPR/Cas 12a assay. 利用RPA-CRISPR/Cas 12a检测方法对犊牛腹泻病原体进行灵敏、特异和快速的现场检测。
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.3389/fcimb.2026.1734185
Yan Wang, Yun Diao, Tianqi Zhang, Fan Zhang, Wei Wang

Calf diarrhea is a common gastrointestinal disease that usually occurs within one month of birth. The disease causes the greatest economic losses to the cattle industry. Currently, a variety of diagnostic methods have been developed for calf diarrhea infections. However, existing methods are still unsatisfactory in terms of sensitivity, specificity, simplicity, cost, and speed.To provide a more sensitive, specific, simpler, and faster detection method, we recently developed an RPA-CRISPR/Cas12a assay that can detect BVDV, BCoV, BRV, and ETEC infections in cattle on-site. Testing for each pathogen is performed in a single test tube, without the need to open the tube in the middle, and can be completed in under 50 minutes.The RPA-CRISPR/Cas12a assay can detect BVDV, BCoV, BRV, and ETEC at concentrations of at least 10 copies/μL. The RPA-CRISPR/Cas12a assay does not produce false-positive results due to the presence of other pathogens. The sensitivity of BCoV, BRV, and ETEC in the RPA-CRISPR/Cas12a quadruple assay is equivalent to that of single qPCR. The sensitivity of BVDV in the quadruple assay is slightly lower than that of the single qPCR method.Due to its sensitivity, specificity, simplicity, and rapidity, the RPA-CRISPR/Cas12a assay is more practical for on-site detection of cattle diarrhea pathogens than any existing detection method.

小牛腹泻是一种常见的胃肠道疾病,通常发生在出生一个月内。这种疾病给养牛业造成了最大的经济损失。目前,小牛腹泻感染的诊断方法多种多样。然而,现有的方法在灵敏度、特异性、简单性、成本和速度等方面仍不尽人意。为了提供一种更灵敏、更特异、更简单、更快速的检测方法,我们最近开发了一种RPA-CRISPR/Cas12a检测方法,可以现场检测牛的BVDV、BCoV、BRV和ETEC感染。每种病原体的检测在单个试管中进行,不需要在中间打开试管,并且可以在50分钟内完成。RPA-CRISPR/Cas12a检测方法可以检测浓度至少为10 copies/μL的BVDV、BCoV、BRV和ETEC。RPA-CRISPR/Cas12a检测不会因为其他病原体的存在而产生假阳性结果。在RPA-CRISPR/Cas12a四联检测中,BCoV、BRV和ETEC的敏感性与单qPCR相当。四联法检测BVDV的灵敏度略低于单次qPCR法。RPA-CRISPR/Cas12a检测具有敏感性、特异性、简便、快速等特点,比现有的任何检测方法都更适合现场检测牛腹泻病原体。
{"title":"Sensitive, specific, and rapid on-site detection of calf diarrhea pathogens using the RPA-CRISPR/Cas 12a assay.","authors":"Yan Wang, Yun Diao, Tianqi Zhang, Fan Zhang, Wei Wang","doi":"10.3389/fcimb.2026.1734185","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1734185","url":null,"abstract":"<p><p>Calf diarrhea is a common gastrointestinal disease that usually occurs within one month of birth. The disease causes the greatest economic losses to the cattle industry. Currently, a variety of diagnostic methods have been developed for calf diarrhea infections. However, existing methods are still unsatisfactory in terms of sensitivity, specificity, simplicity, cost, and speed.To provide a more sensitive, specific, simpler, and faster detection method, we recently developed an RPA-CRISPR/Cas12a assay that can detect BVDV, BCoV, BRV, and ETEC infections in cattle on-site. Testing for each pathogen is performed in a single test tube, without the need to open the tube in the middle, and can be completed in under 50 minutes.The RPA-CRISPR/Cas12a assay can detect BVDV, BCoV, BRV, and ETEC at concentrations of at least 10 copies/μL. The RPA-CRISPR/Cas12a assay does not produce false-positive results due to the presence of other pathogens. The sensitivity of BCoV, BRV, and ETEC in the RPA-CRISPR/Cas12a quadruple assay is equivalent to that of single qPCR. The sensitivity of BVDV in the quadruple assay is slightly lower than that of the single qPCR method.Due to its sensitivity, specificity, simplicity, and rapidity, the RPA-CRISPR/Cas12a assay is more practical for on-site detection of cattle diarrhea pathogens than any existing detection method.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1734185"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computational identification of natural inhibitors targeting GroEL in Leptospira interrogans: an integrative virtual screening and molecular dynamics approach. 钩端螺旋体中靶向GroEL的天然抑制剂的计算鉴定:一种综合虚拟筛选和分子动力学方法。
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2025-01-01 DOI: 10.3389/fcimb.2025.1733096
Guneswar Sethi, Sthitaprajna Sahoo, Su-Cheol Han, Donghyun Shin, Jeong Ho Hwang

Introduction: Leptospirosis is a zoonotic disease caused by Leptospira interrogans and represents a major public health and veterinary concern. The persistence of the pathogen is closely associated with biofilm formation, yet targeted therapeutics are currently unavailable. The GroEL chaperonin, a conserved protein involved in biofilm formation and immunogenicity, was investigated as a potential therapeutic target.

Methods: A structure-based virtual screening approach was performed using a library of 543,503 natural compounds from the Life Chemicals database. Top-ranked ligands were evaluated using molecular docking and physicochemical and pharmacokinetic property analyses. Density functional theory calculations were performed to assess electronic stability, followed by molecular dynamics simulations to evaluate ligand-protein complex stability. Principal component analysis and MM-PBSA binding free energy calculations were subsequently applied to characterize conformational dynamics and binding affinity.

Results: Five compounds (F3385-2019, F1243-0200, F3139-0927, F2801-0179, and F1864-0208) exhibited strong binding affinities toward GroEL, with docking energies ranging from -10.34 to -8.26 kcal/mol. All shortlisted compounds complied with Lipinski's Rule of Five and demonstrated favorable pharmacokinetic properties. Molecular dynamics simulations and MM-PBSA analyses indicated stable ligand-protein interactions. Among the candidates, F1864-0208 and F1243-0200 emerged as the most stable and promising leads, whereas the remaining compounds showed moderate inhibition.

Discussion: This study provides computational evidence supporting GroEL as a viable drug target in L. interrogans. The identified natural compounds may represent promising scaffolds for the development of novel anti-leptospiral agents. Further in vitro and in vivo studies are required to validate their therapeutic efficacy and safety.

简介:钩端螺旋体病是由钩端螺旋体引起的一种人畜共患疾病,是一个主要的公共卫生和兽医问题。病原体的持续存在与生物膜的形成密切相关,但目前尚无靶向治疗方法。GroEL伴侣蛋白是一种参与生物膜形成和免疫原性的保守蛋白,被研究为潜在的治疗靶点。方法:使用Life Chemicals数据库中的543,503种天然化合物库进行基于结构的虚拟筛选方法。通过分子对接、理化和药代动力学分析对排名靠前的配体进行评价。通过密度泛函理论计算来评估电子稳定性,然后通过分子动力学模拟来评估配体-蛋白质复合物的稳定性。随后采用主成分分析和MM-PBSA结合自由能计算来表征构象动力学和结合亲和力。结果:5个化合物(F3385-2019、F1243-0200、F3139-0927、F2801-0179和F1864-0208)对GroEL具有较强的结合亲和力,对接能范围为-10.34 ~ -8.26 kcal/mol。所有候选化合物均符合利平斯基五法则,并表现出良好的药代动力学性质。分子动力学模拟和MM-PBSA分析表明配体-蛋白相互作用稳定。在候选化合物中,F1864-0208和F1243-0200被认为是最稳定和最有希望的先导物,而其余化合物表现出中度抑制作用。讨论:本研究提供了计算证据,支持GroEL作为一种可行的药物靶点。所鉴定的天然化合物可能是开发新型抗钩端螺旋体药物的有希望的支架。需要进一步的体外和体内研究来验证其治疗效果和安全性。
{"title":"Computational identification of natural inhibitors targeting GroEL in <i>Leptospira interrogans</i>: an integrative virtual screening and molecular dynamics approach.","authors":"Guneswar Sethi, Sthitaprajna Sahoo, Su-Cheol Han, Donghyun Shin, Jeong Ho Hwang","doi":"10.3389/fcimb.2025.1733096","DOIUrl":"https://doi.org/10.3389/fcimb.2025.1733096","url":null,"abstract":"<p><strong>Introduction: </strong>Leptospirosis is a zoonotic disease caused by <i>Leptospira interrogans</i> and represents a major public health and veterinary concern. The persistence of the pathogen is closely associated with biofilm formation, yet targeted therapeutics are currently unavailable. The GroEL chaperonin, a conserved protein involved in biofilm formation and immunogenicity, was investigated as a potential therapeutic target.</p><p><strong>Methods: </strong>A structure-based virtual screening approach was performed using a library of 543,503 natural compounds from the Life Chemicals database. Top-ranked ligands were evaluated using molecular docking and physicochemical and pharmacokinetic property analyses. Density functional theory calculations were performed to assess electronic stability, followed by molecular dynamics simulations to evaluate ligand-protein complex stability. Principal component analysis and MM-PBSA binding free energy calculations were subsequently applied to characterize conformational dynamics and binding affinity.</p><p><strong>Results: </strong>Five compounds (F3385-2019, F1243-0200, F3139-0927, F2801-0179, and F1864-0208) exhibited strong binding affinities toward GroEL, with docking energies ranging from -10.34 to -8.26 kcal/mol. All shortlisted compounds complied with Lipinski's Rule of Five and demonstrated favorable pharmacokinetic properties. Molecular dynamics simulations and MM-PBSA analyses indicated stable ligand-protein interactions. Among the candidates, F1864-0208 and F1243-0200 emerged as the most stable and promising leads, whereas the remaining compounds showed moderate inhibition.</p><p><strong>Discussion: </strong>This study provides computational evidence supporting GroEL as a viable drug target in <i>L. interrogans</i>. The identified natural compounds may represent promising scaffolds for the development of novel anti-leptospiral agents. Further <i>in vitro</i> and <i>in vivo</i> studies are required to validate their therapeutic efficacy and safety.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"15 ","pages":"1733096"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the benefits of metagenomic next-generation sequencing for patients experiencing infections after total hip replacement surgery: a retrospective cohort study with a minimum of one year of follow-up. 研究新一代宏基因组测序对全髋关节置换术后感染患者的益处:一项至少随访一年的回顾性队列研究。
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.3389/fcimb.2026.1735867
Jiaqing Zhu, Tianwei Xia, Lu Wang, Xindong Yin, Yong Ma, Jirong Shen

Objective: To explore the clinical significance of metagenomic next-generation sequencing (mNGS) technology in diagnosing and treating periprosthetic joint infection (PJI) following total hip arthroplasty (THA).

Methods: From September 2018 to September 2024, 15 patients with periprosthetic infection after total hip arthroplasty were admitted. There were 11 males and 4 females; ages ranged from 28 to 87 years old, with an average of 63 years old. Infection occurred 6 to 42 months after total hip arthroplasty, with an average of 22.7 months. The infection lasted between 15 and 115 days, averaging 37.6 days. After being admitted to the hospital, joint fluid was collected for bacterial culture and mNGS. Following admission, joint fluid was collected for bacterial culture and mNGS, and antibiotics were adjusted based on the results, with surgery used to control the infection if needed.

Results: Bacterial culture method was positive in 10 cases (66.7%), with a total of 12 pathogenic bacteria types detected. MNGS was positive in 15 cases (100.0%), with a total of 19 pathogenic bacteria types detected. There was a statistically significant difference in the positive rate between the two methods (P < 0.05). Out of the 10 patients, 5 who tested positive using both the bacterial culture method and mNGS test showed identical pathogenic bacterial types, resulting in a 50.0% compliance rate. The testing time (from sample delivery to results) was (3.07 ± 0.96) days for bacterial culture method and (1.67 ± 0.49) days for mNGS test, and the difference was statistically significant (t=5.03, P<0.001). The patients were followed up for 13 to 82 months, with a mean of 40.7 months. In one patient, the infection returned three months after undergoing one-stage revision surgery, while the other 14 patients showed no signs of infection, resulting in an infection control rate of 93.3%.

Conclusion: MNGS can detect the pathogenic bacteria of postoperative PJI after THA more quickly and accurately than the bacterial culture method, which is crucial for guiding antibiotic and surgical treatment combinations for patients with postoperative PJI after THA.

目的:探讨新一代宏基因组测序(mNGS)技术在全髋关节置换术(THA)术后假体周围关节感染(PJI)诊断和治疗中的临床意义。方法:2018年9月至2024年9月收治全髋关节置换术后假体周围感染患者15例。男性11人,女性4人;年龄28 ~ 87岁,平均63岁。感染发生在全髋关节置换术后6 ~ 42个月,平均22.7个月。感染持续15 ~ 115天,平均37.6天。入院后,收集关节液进行细菌培养和mNGS检测。入院后,收集关节液进行细菌培养和mNGS,根据结果调整抗生素,必要时采用手术控制感染。结果:细菌培养法阳性10例(66.7%),共检出12种致病菌。MNGS阳性15例(100.0%),检出病原菌19种。两种方法的阳性率比较,差异有统计学意义(P < 0.05)。10例患者中,5例细菌培养法和mNGS检测结果均为阳性,病原菌类型相同,治疗依从率为50.0%。细菌培养法检测时间(送样至结果)为(3.07±0.96)天,mNGS法检测时间为(1.67±0.49)天,差异有统计学意义(t=5.03, p < 0.05)。结论:mNGS法比细菌培养法更快、更准确地检测出THA术后PJI的病原菌,对指导THA术后PJI患者的抗生素及手术治疗组合具有重要意义。
{"title":"Investigating the benefits of metagenomic next-generation sequencing for patients experiencing infections after total hip replacement surgery: a retrospective cohort study with a minimum of one year of follow-up.","authors":"Jiaqing Zhu, Tianwei Xia, Lu Wang, Xindong Yin, Yong Ma, Jirong Shen","doi":"10.3389/fcimb.2026.1735867","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1735867","url":null,"abstract":"<p><strong>Objective: </strong>To explore the clinical significance of metagenomic next-generation sequencing (mNGS) technology in diagnosing and treating periprosthetic joint infection (PJI) following total hip arthroplasty (THA).</p><p><strong>Methods: </strong>From September 2018 to September 2024, 15 patients with periprosthetic infection after total hip arthroplasty were admitted. There were 11 males and 4 females; ages ranged from 28 to 87 years old, with an average of 63 years old. Infection occurred 6 to 42 months after total hip arthroplasty, with an average of 22.7 months. The infection lasted between 15 and 115 days, averaging 37.6 days. After being admitted to the hospital, joint fluid was collected for bacterial culture and mNGS. Following admission, joint fluid was collected for bacterial culture and mNGS, and antibiotics were adjusted based on the results, with surgery used to control the infection if needed.</p><p><strong>Results: </strong>Bacterial culture method was positive in 10 cases (66.7%), with a total of 12 pathogenic bacteria types detected. MNGS was positive in 15 cases (100.0%), with a total of 19 pathogenic bacteria types detected. There was a statistically significant difference in the positive rate between the two methods (P < 0.05). Out of the 10 patients, 5 who tested positive using both the bacterial culture method and mNGS test showed identical pathogenic bacterial types, resulting in a 50.0% compliance rate. The testing time (from sample delivery to results) was (3.07 ± 0.96) days for bacterial culture method and (1.67 ± 0.49) days for mNGS test, and the difference was statistically significant (t=5.03, P<0.001). The patients were followed up for 13 to 82 months, with a mean of 40.7 months. In one patient, the infection returned three months after undergoing one-stage revision surgery, while the other 14 patients showed no signs of infection, resulting in an infection control rate of 93.3%.</p><p><strong>Conclusion: </strong>MNGS can detect the pathogenic bacteria of postoperative PJI after THA more quickly and accurately than the bacterial culture method, which is crucial for guiding antibiotic and surgical treatment combinations for patients with postoperative PJI after THA.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1735867"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro antibacterial activity of platelet-rich plasma against Gram-positive and Gram-negative pathogens. 富血小板血浆对革兰氏阳性和革兰氏阴性病原菌的体外抗菌活性。
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.3389/fcimb.2026.1757780
Yan Liu, Lei Liu, Jinbing Du, Wenxu Ni, Tingting Zou, Zihan Yuan, Yingkai Xu, Junying Li, Mengyu Shen, Yong Qi, Wanbing Liu

Platelet-rich plasma (PRP) is known as an autologous biological agent that can immensely promote wound healing. Bacterial infection is a common complication of wounds which obstructs wound healing. However, the effect of PRP on bacteria is still inconclusive. This in vitro study evaluated the antibacterial activity of PRP, platelet-poor plasma (PPP) and Frozen-PRP (Fro-PRP) against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Staphylococcus aureus, and Enterococcus faecalis. The antimicrobial activity was performed using modified agar diffusion method, colony-forming units counting test, and bacterial growth curve analysis. The results showed that PRP, PPP and Fro-PRP had antimicrobial effects on five bacterial strains including Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Staphylococcus aureus, and Enterococcus faecalis. The antimicrobial activity of PRP was significantly stronger than that of Fro-PRP and PPP. To a certain extent, frozen storage may reduce the antibacterial ability of PRP. Overall, our study demonstrates that PRP and other platelet derived products seem to be a promising alternative tool for infected wounds treatment.

富血小板血浆(PRP)被认为是一种自体生物制剂,可以极大地促进伤口愈合。细菌感染是伤口的常见并发症,它会阻碍伤口愈合。然而,PRP对细菌的影响仍然没有定论。本体外研究评估了PRP、血小板贫血浆(PPP)和冷冻PRP (ro-PRP)对大肠杆菌、肺炎克雷伯菌、阴沟肠杆菌、金黄色葡萄球菌和粪肠球菌的抑菌活性。采用改良琼脂扩散法、菌落形成单位计数试验和细菌生长曲线分析进行抑菌活性测定。结果表明,PRP、PPP和Fro-PRP对大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌、金黄色葡萄球菌和粪肠球菌5种细菌均有抗菌作用。PRP的抑菌活性显著强于Fro-PRP和PPP。冷冻保存在一定程度上降低了PRP的抗菌能力。总的来说,我们的研究表明,PRP和其他血小板衍生产品似乎是治疗感染伤口的一种有希望的替代工具。
{"title":"<i>In vitro</i> antibacterial activity of platelet-rich plasma against Gram-positive and Gram-negative pathogens.","authors":"Yan Liu, Lei Liu, Jinbing Du, Wenxu Ni, Tingting Zou, Zihan Yuan, Yingkai Xu, Junying Li, Mengyu Shen, Yong Qi, Wanbing Liu","doi":"10.3389/fcimb.2026.1757780","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1757780","url":null,"abstract":"<p><p>Platelet-rich plasma (PRP) is known as an autologous biological agent that can immensely promote wound healing. Bacterial infection is a common complication of wounds which obstructs wound healing. However, the effect of PRP on bacteria is still inconclusive. This <i>in vitro</i> study evaluated the antibacterial activity of PRP, platelet-poor plasma (PPP) and Frozen-PRP (Fro-PRP) against <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Enterobacter cloacae</i>, <i>Staphylococcus aureus</i>, and <i>Enterococcus faecalis</i>. The antimicrobial activity was performed using modified agar diffusion method, colony-forming units counting test, and bacterial growth curve analysis. The results showed that PRP, PPP and Fro-PRP had antimicrobial effects on five bacterial strains including <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Enterobacter cloacae</i>, <i>Staphylococcus aureus</i>, and <i>Enterococcus faecalis</i>. The antimicrobial activity of PRP was significantly stronger than that of Fro-PRP and PPP. To a certain extent, frozen storage may reduce the antibacterial ability of PRP. Overall, our study demonstrates that PRP and other platelet derived products seem to be a promising alternative tool for infected wounds treatment.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1757780"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-dimensional epidemiology of pediatric acute respiratory tract infection in Ningbo, China (2020-2024): age-specific susceptibility, pathogen dynamics, and epidemiological trends. 宁波市儿童急性呼吸道感染的多维流行病学(2020-2024):年龄特异性易感性、病原体动态和流行病学趋势
IF 4.8 2区 医学 Q2 IMMUNOLOGY Pub Date : 2026-02-02 eCollection Date: 2026-01-01 DOI: 10.3389/fcimb.2026.1662777
Min Jiang, Qian Sun, Xuedan Qiu, Qianru Mei, Yanye Tu, Feng Wang, Qingcao Li

Background: Pediatric acute respiratory tract infection (ARTI) constitutes a major global health threat. Since 2020, global containment measures have disrupted pathogen circulation patterns, leading to altered epidemiological profiles across multiple pathogens with marked regional heterogeneity. Current research in Ningbo predominantly focuses on single-pathogen surveillance or short-term monitoring, lacking systematic analysis of multi-pathogen interactive dynamics, age-specific susceptibility mechanisms, and co-infections.

Methods: Clinical data from all 191,967 pediatric patients with ARTI at Ningbo LiHuili Hospital (2020-2024) were collected. Laboratory testing including influenza A/B virus (IFV-A/B) detection, Mycoplasma pneumoniae (MP) testing, 13 respiratory pathogens analysis, and bacterial culture was systematically integrated and analyzed.

Results: From 2020 and 2024, the number of ARTI cases initially increased and then decreased, peaking in 2023. The incidence was highest in autumn and lowest in summer. Among all cases, 75,001 (39.07%) were diagnosed with acute lower respiratory infection (ALRI), with children aged 6 years exhibiting the highest susceptibility. Of the 41,766 cases tested, the overall pathogen detection rate was 67.61%. IFV-A/B, Human Parainfluenza Virus (HPIV), and Human Adenovirus (HAdV) were more frequently detected in acute upper respiratory tract infections (AURI) (P < 0.05), while Human Rhinovirus (HRV), Respiratory Syncytial Virus (RSV), and MP were predominantly identified in ALRI cases (P < 0.05). Each pathogen exhibited age-specific susceptibility patterns. Several pathogens, such as IFV-A, MP, and HAdV, displayed distinctive epidemic peaks. Co-infections were common, with a 17.38% co-infection rate observed in the group tested for 13 respiratory pathogens, and a higher co-infection rate of 39.49% when testing combined respiratory pathogens and bacteria. Correlation analysis among pathogens revealed predominant antagonistic interactions between viruses, positive associations among bacteria, and generally positive interactions between viruses and bacteria, though overall correlation strengths were weak.

Conclusion: Pediatric ARTI exhibit age-specific susceptibility and pathogen variation. The 2023-2024 resurgence demands precision control strategies for optimized intervention.

背景:儿童急性呼吸道感染(ARTI)是一个主要的全球健康威胁。自2020年以来,全球遏制措施扰乱了病原体的传播模式,导致多种病原体的流行病学特征发生了变化,且存在明显的区域异质性。宁波市目前的研究主要集中在单病原体监测或短期监测,缺乏多病原体相互作用动态、年龄特异性易感机制和共感染的系统分析。方法:收集宁波市李慧丽医院2020-2024年191,967例ARTI患儿的临床资料。对流感A/B病毒(IFV-A/B)检测、肺炎支原体(MP)检测、13种呼吸道病原菌分析、细菌培养等实验室检测结果进行系统整合分析。结果:2020 - 2024年ARTI病例数呈先上升后下降趋势,2023年达到高峰。发病率以秋季最高,夏季最低。在所有病例中,75,001例(39.07%)被诊断为急性下呼吸道感染(ALRI),其中6岁儿童易感性最高。检出病例41766例,病原菌检出率为67.61%。急性上呼吸道感染(AURI)中以IFV-A/B、人副流感病毒(HPIV)和人腺病毒(hav)检出较多(P < 0.05),而急性上呼吸道感染(ALRI)中以人鼻病毒(HRV)、呼吸道合胞病毒(RSV)和MP检出较多(P < 0.05)。每种病原体都表现出年龄特异性的易感模式。若干病原体,如IFV-A、MP和hav,呈现出明显的流行高峰。共感染较为常见,13种呼吸道病原体检测组共感染率为17.38%,呼吸道病原体与细菌联合检测组共感染率为39.49%。病原菌间的相关分析显示,病毒间的相互作用主要为拮抗作用,细菌间的相互作用为正相关,病毒与细菌间的相互作用总体为正相关,但总体相关强度较弱。结论:儿童ARTI表现出年龄特异性易感性和病原体变异。2023-2024年的复苏需要精确的控制策略来优化干预。
{"title":"Multi-dimensional epidemiology of pediatric acute respiratory tract infection in Ningbo, China (2020-2024): age-specific susceptibility, pathogen dynamics, and epidemiological trends.","authors":"Min Jiang, Qian Sun, Xuedan Qiu, Qianru Mei, Yanye Tu, Feng Wang, Qingcao Li","doi":"10.3389/fcimb.2026.1662777","DOIUrl":"https://doi.org/10.3389/fcimb.2026.1662777","url":null,"abstract":"<p><strong>Background: </strong>Pediatric acute respiratory tract infection (ARTI) constitutes a major global health threat. Since 2020, global containment measures have disrupted pathogen circulation patterns, leading to altered epidemiological profiles across multiple pathogens with marked regional heterogeneity. Current research in Ningbo predominantly focuses on single-pathogen surveillance or short-term monitoring, lacking systematic analysis of multi-pathogen interactive dynamics, age-specific susceptibility mechanisms, and co-infections.</p><p><strong>Methods: </strong>Clinical data from all 191,967 pediatric patients with ARTI at Ningbo LiHuili Hospital (2020-2024) were collected. Laboratory testing including influenza A/B virus (IFV-A/B) detection, <i>Mycoplasma pneumoniae</i> (MP) testing, 13 respiratory pathogens analysis, and bacterial culture was systematically integrated and analyzed.</p><p><strong>Results: </strong>From 2020 and 2024, the number of ARTI cases initially increased and then decreased, peaking in 2023. The incidence was highest in autumn and lowest in summer. Among all cases, 75,001 (39.07%) were diagnosed with acute lower respiratory infection (ALRI), with children aged 6 years exhibiting the highest susceptibility. Of the 41,766 cases tested, the overall pathogen detection rate was 67.61%. IFV-A/B, Human Parainfluenza Virus (HPIV), and Human Adenovirus (HAdV) were more frequently detected in acute upper respiratory tract infections (AURI) (<i>P</i> < 0.05), while Human Rhinovirus (HRV), Respiratory Syncytial Virus (RSV), and MP were predominantly identified in ALRI cases (<i>P</i> < 0.05). Each pathogen exhibited age-specific susceptibility patterns. Several pathogens, such as IFV-A, MP, and HAdV, displayed distinctive epidemic peaks. Co-infections were common, with a 17.38% co-infection rate observed in the group tested for 13 respiratory pathogens, and a higher co-infection rate of 39.49% when testing combined respiratory pathogens and bacteria. Correlation analysis among pathogens revealed predominant antagonistic interactions between viruses, positive associations among bacteria, and generally positive interactions between viruses and bacteria, though overall correlation strengths were weak.</p><p><strong>Conclusion: </strong>Pediatric ARTI exhibit age-specific susceptibility and pathogen variation. The 2023-2024 resurgence demands precision control strategies for optimized intervention.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"16 ","pages":"1662777"},"PeriodicalIF":4.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Cellular and Infection Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1